高密度脂蛋白胆固醇

ɡāo mì dù zhī dàn bái dǎn ɡù chún
  • High-density lipoprotein cholesterol;HDL cholesterol
高密度脂蛋白胆固醇高密度脂蛋白胆固醇
  1. 高尿酸血症、低密度脂蛋白胆固醇增高和高密度脂蛋白胆固醇降低是青年冠心病的主要特点;

    The increase of hyperuricemia and LDL cholesterol and the decrease of HDL cholesterol are the main characteristics of young men with CAD .

  2. 有研究显示,1天喝3杯绿茶能偶降低11%心脏病发病率,还能提高对人体有好处的高密度脂蛋白胆固醇水平。

    Studies have shown that drinking three cups of green tea a day can decrease heart attack rate by 11 percent , and that it can also raise levels of " good " HDL cholesterol .

  3. 维生素C对高密度脂蛋白胆固醇测定的干扰及其机制研究

    Interference of vitamin C on detection of HDL - C and its mechanism

  4. 肾病患者血清载脂蛋白A1、B、高密度脂蛋白胆固醇水平的测定价值

    Concentrations of apolipoprotein A1 、 apolipoprotein B and high-density lipoproteins in serum of renal disease patients : a pragmatic approach of probe into

  5. 用酶法测定甘油三酯(TG)和胆固醇(TC),用沉淀法测定高密度脂蛋白胆固醇;

    High density lipoprotein cholesterol ( HDLCh ) was detected with sedimentary method .

  6. 目的探讨老年脑梗死患者血清高密度脂蛋白胆固醇(HDLc)含量的变化。

    Objective To investigate the levels of serum high density lipoprotein cholesterol ( HDL-C ) in aged patients with cerebral infarction .

  7. 胆固醇酯转运蛋白D~(442)→G突变对高密度脂蛋白胆固醇水平的影响

    Effect of the Mutation D ~ ( 442 )→ G in Cholesteryl Ester Transfer Protein Gene on the Level of Serum High Density Lipoprotein Cholesterol

  8. 在B2B2基因型中,当S突变为X时,血浆高密度脂蛋白胆固醇水平明显升高,P<001。

    When S mutated to X , there was a significant increase of HDL in B 2B 2 genotype ( P < 0 01 ) .

  9. DM组中血清脂联素与MS、男性、体重指数呈负相关,与高密度脂蛋白胆固醇呈正相关。

    Adiponectin level was correlated negatively with MS , maleness , and BMI , and positively with HDL-C in DM group .

  10. CAI与PAI患者血清高密度脂蛋白胆固醇及亚组份水平的研究

    A study of serum high density lipoprotein cholesterol and its subclass levels in CAI and Pai patients

  11. 目的:观察较高剂量泛硫乙胺(Patethine,潘特生)治疗低水平高密度脂蛋白胆固醇(HDL-C)的疗效及安全性。

    Objective : To evaluate the efficacy and safety of larger dose of pantethine on treating low level of serum high density lipoprotein cholesterol .

  12. 结论胆固醇酯转运蛋白第15外显子D442→G突变与高密度脂蛋白胆固醇水平升高密切相关。

    Conclusion Exon 15 D ~ ( 442 )→ G mutation in cholesteryl ester transfer protein is related to the elevated level of serum high density lipoprotein cholesterol .

  13. 试验组高密度脂蛋白胆固醇有所升高,差异不显著(P0.05)。

    Level of high-density lipoprotein cholesterol in the test group tended to increase , but was not significant compared with the control ( P0.05 ) .

  14. 高密度脂蛋白胆固醇(HDL-C)两组有轻度上升,G1组上升3.6%,G2组上升了5.5%。

    The level of HDL-C in both groups increased by 3.6 % and 5.5 % respectively .

  15. 目的研究高密度脂蛋白胆固醇(HDL-C)水平与冠状动脉疾病(CAD)及高血压的关系。

    Objective To explore the relationship between high density lipoprotein cholesterol ( HDL-C ) levels and coronary artery diseases ( CAD ) and hypertension .

  16. 血脂在总胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇方面,组间比较无统计学差异(P0.05)。

    Lipid The levels of TG 、 TC 、 LDL-C and HDL-C showed no significant difference between the two groups ( P 0 . 05 ) . 7 .

  17. 目的:探讨高密度脂蛋白胆固醇(HDLC)与冠状动脉病变程度的关系以及影响HDLC水平的其他危险因素。

    Objective : To explore the relationship between high density lipoprotein-cholesterin ( HDL-C ) and the extent of coronary artery diseases and other drisk factors affecting the level of HDL-C.

  18. 目的探讨某国产试剂(B公司)高密度脂蛋白胆固醇(HDL-C)试剂对天门冬氨酸氨基转移酶(AST)测定结果的影响。

    Objective To explore the influence of a homemade high density lipoprotein cholesterol ( HDL-C ) reagent to interfere testing serum aspartate aminotransferase ( AST ) .

  19. 大型多中心随机研究发现,血清中高密度脂蛋白胆固醇(high-densitylipoproteincholesterol,HDL-C)水平与心血管疾病发生率呈负相关。

    It is found out by many previous randomized researches that high-density lipoprotein cholesterol level in serum has a negative correlation with cardiovascular disease occurrence .

  20. 治疗后体重指数、血压有轻微下降,但无统计学差异(P>0.05),总甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)较治疗前有所改善(P<0.05)。

    The lipid profile improved after treatment ( P < 0.05 ), and the BMI and blood pressure slightly decreased but no significant difference .

  21. 在冠心病组中,TT基因型血浆高密度脂蛋白胆固醇水平明显低于CC基因型(P<0.001)。

    The plasma levels of HDLC were differed significantly between the TT genotype and the CC genotype ( P < 0.001 ) in CHD group .

  22. 高密度脂蛋白胆固醇及其亚组分(HDLc,HDL2C,HDL3C)有降低趋势,但无显著性差异(P>0.05);

    High density lipoprotein cholesterol and its subfraction ( HDL C , HDL 2 C , HDL 3 C ) decreased slightly , but without statistical significance ( P > 0.05 ) .

  23. 目的了解上海社区人群高密度脂蛋白胆固醇(HDL-C)水平、低高密度脂蛋白血症的患病情况及伴随的其他代谢异常情况。

    Objective To determine the mean high density lipoprotein cholesterol ( HDL-C ) level in Shanghai community and the associated metabolic disorder .

  24. 高密度脂蛋白胆固醇(HDL-CH)异常的危险因素研究

    Study On Multiple Risk Factors Of High Density Lipoprotein Cholesterol Disorder

  25. 目的探讨甘油三酯/高密度脂蛋白胆固醇(TG/HDL-C)比值对冠心病(CHD)的诊断价值。

    Objective To study the value of serum triglyceride / high-density lipoprotein cholesterol ( TG / HDL-C ) ratio in the diagnosis of coronary heart disease ( CHD ) .

  26. 结果:治疗后患者血清高密度脂蛋白胆固醇升高、低密度脂蛋白胆固醇降低、动脉硬化指数下降(P<0.01);

    Results : Compared with the blood lipid level before treatment , the high density lipoprotein of cholesterol ( HDL-C ) was increased , the low density lipoprotein of cholesterol ( LDL-C ), atherogenic index ( AI ) was decreased ( P0.01 ) .

  27. 合成药NO-1886是脂蛋白脂肪酶(LPL)的激动剂,能降低血浆甘油三酯(TG)并升高高密度脂蛋白胆固醇(HDL-c)水平。

    Synthetic compound NO-1886 is a lipoprotein lipase activator which lowers plasma triglycerides and elevates high-density lipoprotein cholesterol ( HDL-C ) .

  28. 直接测定法测定高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C);

    The levels of high density lipoprotein cholesterol ( HDL-C ) and low density lipoprotein cholesterol ( LDL-C ) were measured by direct method .

  29. 有氧训练被认为可部分通过增加血清中高密度脂蛋白胆固醇(HDL-C)水平减少心血管疾病的风险。

    Background Aerobic exercise is believed to reduce the risk of cardiovascular disease partially through increasing serum levels of high-density lipoprotein cholesterol ( HDL-C ) .

  30. 目的探讨中老年健康人群血清总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)水平及与相关个体因素的关系。

    Objective To study the relationship between lifestyle and serum total cholesterol ( TC ), low-density lipoprotein cholesterol ( LDL-C ), high-density lipoprotein cholesterol ( HDL-C ) .